journal article·2018-11-12Open access

Nano-encapsulated HHC10 host defense peptide (HDP) reduces the growth of Escherichia coli via multimodal mechanisms

Ankur Sharma, Kalpesh Vaghasiya, Eupa Ray, Rahul Kumar Verma

Abstract

The eradication of several pathogenic drug resistant "Superbug" such as Escherichia coli became difficult especially in chronic infections using existing antibiotics due to the emergence of antibiotic resistance. Owing to their unique antibacterial properties, host defense peptides (HDP) have gained significant attention to combat colonization of bacteria. This study aims designing delivery systems for HHC10 peptide to target bacteria inside the cells might be a promising approach by protecting from degradation, controlling the release, enhancing the susceptibility of target microbes and improving bioavailability. Nano-formulated HHC10 was evaluated for its efficacy (CFU assay) and possible mechanism of action (membrane interaction and apoptosis) against E. coli. Dose-dependent inhibition of E. coli growth is observed for nano-encapsulated and bare HHC10 and encapsulated form remain non-toxic to macrophage mouse cells (RAW264.6) up to 20 μM. Mechanistic analyses using transmission electron microscopy and flow cytometry techniques revealed that bactericidal activity of HHC10-NP progresses via a multimodal mechanism of bacterial cell death by cell-membrane lysis on direct interaction with bacteria while through induction of the apoptotic death pathway inside the host cells. These results offer an insight on future strategies for the development and application of antimicrobial peptides as antibacterial alternatives. Controlled delivery of HHC10 peptide from PLGA-NP kills bacteria by two different mechanism: (i) direct killing: HHC10 disintegrate the cell membrane of bacteria by electrostatic interactions and (ii) indirect killing: induction of apoptosis in bacteria infect cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Bacteriophages and microbial interactions · Antibiotic Resistance in Bacteria

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Nano Science and Technology (INST)

Funding

Department of Science and Technology

References (38)

Show source-provided references
1. 10.1179/2047773215Y.000000003010.1179/2047773215Y.0000000030 ↗
2. 10.1016/j.nmni.2015.02.00710.1016/j.nmni.2015.02.007 ↗
3. 10.1517/17425247.5.9.93110.1517/17425247.5.9.931 ↗
4. 10.1056/NEJMp121509310.1056/NEJMp1215093 ↗
5. 10.1128/microbiolspec.VMBF-0016-201510.1128/microbiolspec.VMBF-0016-2015 ↗
6. 10.1016/j.ijantimicag.2013.04.00710.1016/j.ijantimicag.2013.04.007 ↗
7. Blumhardt M. Antimicrobial peptides: immunomodulatory and therapeutic potential for use in Atlantic Salmon (Salmo Salar) [master’s thesis]. University of Tasmania; 2015.
8. 10.3201/eid1805.11115310.3201/eid1805.111153 ↗
9. 10.1016/S0005-2736(99)00198-410.1016/S0005-2736(99)00198-4 ↗
10. 10.1586/14787210.5.6.95110.1586/14787210.5.6.951 ↗
11. 10.1080/20477724.2016.119503610.1080/20477724.2016.1195036 ↗
12. 10.1016/j.ijantimicag.2004.09.00510.1016/j.ijantimicag.2004.09.005 ↗
13. 10.3109/07388551.2011.59442310.3109/07388551.2011.594423 ↗
14. Nijnik A, Hancock R. Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections. Emerg Health Treats J. 2009;2:e1.
15. 10.1016/j.ijpharm.2017.11.04610.1016/j.ijpharm.2017.11.046 ↗
16. 10.3389/fmicb.2015.0037210.3389/fmicb.2015.00372 ↗
17. 10.2147/DDDT.S14745010.2147/DDDT.S147450 ↗
18. 10.3109/1073119930911736610.3109/10731199309117366 ↗
19. 10.2174/156802661666616071314333110.2174/1568026616666160713143331 ↗
20. 10.1038/nrmicro268810.1038/nrmicro2688 ↗
21. 10.1089/mdr.2012.014910.1089/mdr.2012.0149 ↗
22. 10.3390/antibiotics304050910.3390/antibiotics3040509 ↗
23. 10.1038/nbt126710.1038/nbt1267 ↗
24. 10.1016/bs.apcsb.2014.12.00110.1016/bs.apcsb.2014.12.001 ↗
25. 10.1016/j.micromeso.2016.08.00910.1016/j.micromeso.2016.08.009 ↗
26. 10.3390/molecules2302049710.3390/molecules23020497 ↗
27. 10.1080/21691401.2018.143418610.1080/21691401.2018.1434186 ↗
28. 10.2134/jeq2003.368010.2134/jeq2003.3680 ↗
29. 10.1016/j.tube.2015.05.00210.1016/j.tube.2015.05.002 ↗
30. 10.1080/21691401.2016.120225710.1080/21691401.2016.1202257 ↗
31. 10.1081/BIO-20003963510.1081/BIO-200039635 ↗
32. Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P & T. 2015;40:344–352.
33. 10.1586/14787210.6.6.88710.1586/14787210.6.6.887 ↗
34. 10.1016/j.chemphyslip.2011.09.00410.1016/j.chemphyslip.2011.09.004 ↗
35. 10.1021/cb800240j10.1021/cb800240j ↗
36. 10.1002/psc.270810.1002/psc.2708 ↗
37. 10.1016/j.bbamem.2015.10.01310.1016/j.bbamem.2015.10.013 ↗
38. 10.1021/acschembio.7b0050410.1021/acschembio.7b00504 ↗